# Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA

> **NCT00858780** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 91 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Etanercept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00858780
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2013-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858780, "Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00858780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*